Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-25-000024

Director acquired 7,841 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anderson Kenneth Carl · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-04-01 Grant or award : show line 1 in the form +7,841 $1.44 $11,252 127,609 D
Loading xslF345X05/wk-form4_1743711094.xml…